Jack Ball

Jack T.
Ball is currently Director at Carterra, Inc., SwitchGear Genomics, Inc., RealBio Technology, Inc., ViroCyt, Inc. (since 2013), KromaTid, Inc., and President at Tyball Associates, Inc. Former positions include Chief Executive Officer at Amnis Corp., Chief Executive Officer & Director at Solulink, Inc. (2013–2019), Executive Chairman at Aquaro Histology, Inc., Director at Celsee LLC, 3D Biomatrix, Inc., Swift Biosciences, Inc. (2010–2021), PHASIQ, Inc., NanoCellect Biomedical, Inc. (2021–2023), Cytek Biosciences, Inc. (Independent Director, 2025–2026), Essen Instruments, Inc., Senior VP & General Manager-Life Sciences Group at Orchid Cellmark, Inc., President-North America Sales at Amersham Pharmacia Biotech, Inc. (2012–2013), Chief Commercial Officer at Accuri Cytometers, Inc. (2006–2011), Molecular Probes, Inc., and Principal at GE Healthcare Bio-Sciences, Inc. Education includes undergraduate studies at the University of Georgia.